{
    "2019-12-09": [
        [
            {
                "time": "",
                "original_text": "又崩了！4万亿的板块受重挫！风向标彻底变了嗎？ 连续下跌",
                "features": {
                    "keywords": [
                        "崩盘",
                        "重挫",
                        "风向标",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "又崩了！4万亿的板块早盘重挫，千亿市值龙头股带头下跌，年内白马股纷纷卧倒 连续下跌",
                "features": {
                    "keywords": [
                        "崩盘",
                        "早盘重挫",
                        "龙头股",
                        "白马股",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "2020 | 医药大变革新时代淘汰赛下的战略选择：与偕行，因势而动",
                "features": {
                    "keywords": [
                        "医药",
                        "大变革",
                        "淘汰赛",
                        "战略选择"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药股全线走低，恒瑞医药、长春高新双双跌超4%",
                "features": {
                    "keywords": [
                        "医药股",
                        "全线走低",
                        "恒瑞医药",
                        "长春高新",
                        "跌超4%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020年投资策略报告：大浪淘沙，沉者为金",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资策略",
                        "大浪淘沙",
                        "沉者为金"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【国盛医药张金洋团队】医药行业2020年度策略：与偕行，因势而动 ——医药大变革新时代淘汰赛下的战略选择",
                "features": {
                    "keywords": [
                        "医药行业",
                        "年度策略",
                        "大变革",
                        "淘汰赛",
                        "战略选择"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}